AJP - Renal AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (April 11, 2007). doi:10.1152/ajprenal.00050.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/F398    most recent
00050.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velez, J. C. Q
Right arrow Articles by Janech, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velez, J. C. Q
Right arrow Articles by Janech, M. G.
Submitted on February 1, 2007
Accepted on April 5, 2007

Characterization of Renin-Angiotensin-System Enzyme Activities in Cultured Mouse Podocytes

Juan Carlos Q Velez1*, Alison M Bland2, John M Arthur1, John R. Raymond1, and Michael G. Janech2

1 Research, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States; Medicine/Nephrology, Medical University of South Carolina, Charleston, South Carolina, United States
2 Medicine/Nephrology, Medical University of South Carolina, Charleston, South Carolina, United States

* To whom correspondence should be addressed. E-mail: velezj{at}musc.edu.

Intraglomerular angiotensin-II (ANG-II) has been linked to glomerular injury. However, little is known whether podocytes (POD) contribute to intraglomerular ANG-II homeostasis. The aim of the study was to examine the processing of angiotensin substrates by cultured POD. Our approach was to use MALDI-TOF mass spectrometry for peptide determination from conditioned cell media, using customized AQUA-peptides for quantification. Immortalized mouse POD were incubated with 1-2mcM of angiotensin-I (ANG-I), ANG-II or the renin substrate angiotensin-(1-14) (ANG-1-14), for different time intervals, and co-incubated in parallel with various inhibitors. Human mesangial cells (MES) were used as controls. We found that POD incubated with 1mcM of ANG-I primarily formed angiotensin-(1-9) (ANG-1-9) and angiotensin-(1-7) (ANG-1-7). In contrast, MES incubated with ANG-I primarily generated ANG-II. In POD, ANG-1-7 was the predominant product and its formation was inhibited by a neprilysin (NEP) inhibitor. Modest ACE activity was also detected in POD, although only after cells were incubated with 2mcM of ANG-I. In addition, we observed that POD degraded ANG-II into angiotensin-III (ANG-III) and ANG-1-7. While an aminopeptidase-A (APA) inhibitor inhibited the formation of ANG-III, an ACE2 inhibitor led to ANG-II accumulation. Furthermore, we found that POD converted ANG-1-14 into ANG-I and ANG-1-7. This conversion was inhibited by a renin inhibitor. These findings demonstrate that POD express a functional intrinsic renin-angiotensin-system (RAS) characterized by NEP, APA, ACE2 and renin activities that predominantly lead to ANG-1-7 and ANG-1-9 formation, as well as ANG-II degradation. These findings may reflect a specific role of POD in maintaining intraglomerular RAS balance.




This article has been cited by other articles:


Home page
HypertensionHome page
J. C. Q. Velez, K. J. Ryan, C. E. Harbeson, A. M. Bland, M. N. Budisavljevic, J. M. Arthur, W. R. Fitzgibbon, J. R. Raymond, and M. G. Janech
Angiotensin I Is Largely Converted to Angiotensin (1-7) and Angiotensin (2-10) by Isolated Rat Glomeruli
Hypertension, May 1, 2009; 53(5): 790 - 797.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. D. Burns and N. Li
Letter to the Editor
Am J Physiol Renal Physiol, March 1, 2009; 296(3): F666 - F666.
[Full Text] [PDF]


Home page
Exp PhysiolHome page
M. J. Soler, J. Wysocki, and D. Batlle
Angiotensin-converting enzyme 2 and the kidney
Exp Physiol, May 1, 2008; 93(5): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Whaley-Connell, J. Habibi, R. Nistala, S. A. Cooper, P. R. Karuparthi, M. R. Hayden, N. Rehmer, V. G. DeMarco, B. T. Andresen, Y. Wei, et al.
Attenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin Treatment
Hypertension, February 1, 2008; 51(2): 474 - 480.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.